» Articles » PMID: 26617181

How Do Scores on the ADAS-Cog, MMSE, and CDR-SOB Correspond?

Overview
Specialties Neurology
Psychology
Date 2015 Dec 1
PMID 26617181
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Clinicians and researchers who measure cognitive dysfunction often use the Alzheimer's Disease Assessment Scale--Cognitive Subscale (ADAS-Cog), the Mini-Mental State Examination (MMSE), or the Clinical Dementia Rating scale (CDR-SOB). But, the use of different measures can make it difficult to compare data across patients or studies. What is needed is a simple chart that shows how scores on these three important measures correspond to each other.

Methods: Using data from 1709 participants from the Alzheimer's Disease Neuroimaging Initiative and item response theory-based statistics, we analyzed how scores on each measure, the ADAS-Cog, the MMSE, and the CDR-SOB, correspond.

Results: Results indicated multiple inflections in CDR-SOB and ADAS-Cog scores within a given MMSE score, suggesting that the CDR-SOB and ADAS-Cog are more precise in measuring the severity of cognitive dysfunction than the MMSE.

Conclusions: This study shows how scores on these three popular measures of cognitive dysfunction correspond to each other, which is very useful information for both researchers and clinicians.

Citing Articles

Mixture Disease Progression Model to Predict and Cluster the Long-Term Trajectory of Cognitive Decline in Alzheimer's Disease.

Hanazawa R, Sato H, Hirakawa A Ther Innov Regul Sci. 2024; 59(2):264-277.

PMID: 39671047 DOI: 10.1007/s43441-024-00708-4.


Personalized diet order compliance is associated with an improved functional independence measure (FIM) score in elderly patients: An eight-week follow-up study in a convalescent hospital.

Cho J, Ha S, Son M PLoS One. 2024; 19(12):e0314394.

PMID: 39625891 PMC: 11614235. DOI: 10.1371/journal.pone.0314394.


Reliability of the assessment of the clinical dementia rating scale from the analysis of medical records in comparison with the reference method.

Dauphinot V, Calvi S, Moutet C, Xie J, Dautricourt S, Batsavanis A Alzheimers Res Ther. 2024; 16(1):198.

PMID: 39238042 PMC: 11376013. DOI: 10.1186/s13195-024-01567-9.


Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study.

Rentz D, Rosenberg P, Sperling R, Donohue M, Raman R, Liu A J Prev Alzheimers Dis. 2024; 11(4):814-822.

PMID: 39044489 PMC: 11266445. DOI: 10.14283/jpad.2024.123.


Impact of the Ventricle Size on Alzheimer's Disease Progression: A Retrospective Longitudinal Study.

Lee J, Heo D, Choi K, Kim H Dement Neurocogn Disord. 2024; 23(2):95-106.

PMID: 38720825 PMC: 11073924. DOI: 10.12779/dnd.2024.23.2.95.